Xenik Pharmaceuticals Private Limited
About Xenik Pharmaceuticals Private Limited
Data last updated:
Xenik Pharmaceuticals Private Limited is a private limited company based in Silchar, Assam, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 28 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U51909AS2017PTC018166.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Pijush Kanti Dev and Madhuri Dey.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at C/O Sandip Kumar Dey Durga Sankar Lane Ambicapatty, Silchar, Assam, India – 788004.
As per the financials filed for FY 2019, the company reported a revenue of ₹7.81 Lakh. For the same year it recorded a net profit of ₹5,801 (net margin 0.7%) and EBITDA of ₹35,885 (EBITDA margin 4.6%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Sandip Kumar Dey Durga Sankar Lane Ambicapatty, Silchar, Assam, India – 788004
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Xenik Pharmaceuticals Private Limited
The main business activity of Xenik Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Xenik Pharmaceuticals Private Limited FY 2019 filings available
Xenik Pharmaceuticals Private Limited reported revenue of ₹7.81 Lakh for FY 2019.
Financial Statement Summary of Xenik Pharmaceuticals Private Limited
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹35,885 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹5,801 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Xenik Pharmaceuticals Private Limited
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 4.6% | •••• |
| Net Profit Margin | 0.7% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Xenik Pharmaceuticals are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Xenik Pharmaceuticals Private Limited
Xenik Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Civet Pharmaceuticals Private Limited | ₹7.89 Lakh (FY 2023) | •••• | •••• | -27.0% | •••• | Patna, Bihar, India |
| Wealthkind Pharmaceuticals India Private Limited | ₹7.86 Lakh (FY 2019) | •••• | •••• | •••• | Lucknow, Uttar Pradesh, India | |
| Sonrisa Pharmaceuticals Private Limited | ₹7.84 Lakh (FY 2024) | •••• | •••• | 17.0% | •••• | Delhi, India |
| Fulkoz Pharmaceuticals (OPC) Private Limited | ₹7.83 Lakh (FY 2025) | •••• | •••• | •••• | Nagpur, Maharashtra, India | |
| Druson Pharmaceuticals Private Limited | ₹7.83 Lakh (FY 2024) | •••• | •••• | •••• | Una, Himachal Pradesh, India | |
| Xenik Pharmaceuticals Private Limited this company | ₹7.81 Lakh (FY 2019) | •••• | •••• | •••• | Silchar, Assam, India | |
| Ipsi Pharmaceuticals Private Limited | ₹7.79 Lakh (FY 2023) | •••• | •••• | •••• | Delhi, India | |
| Lyk Pharmaceuticals Private Limited | ₹7.77 Lakh (FY 2024) | •••• | •••• | •••• | Bilaspur, Chhattisgarh, India | |
| Pentcure Pharmaceuticals Private Limited | ₹7.77 Lakh (FY 2020) | •••• | •••• | 54.0% | •••• | Lucknow, Uttar Pradesh, India |
| Truehealth Pharmaceuticals Private Limited | ₹7.73 Lakh (FY 2025) | •••• | •••• | 47.0% | •••• | Bangalore, Karnataka, India |
| Akhilam Pharmaceuticals Pvt Ltd | ₹7.7 Lakh (FY 2024) | •••• | •••• | 4.0% | •••• | Kannur, Kerala, India |
Peers are the five companies nearest above and the five nearest below Xenik Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Xenik Pharmaceuticals Private Limited
Xenik Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pijush Kanti Dev | Director | 28 Sep 2017 | 9 Years 0 Months | Current |
| Madhuri Dey | Director | 28 Sep 2017 | 9 Years 0 Months | Current |
| Sandip Dey | Director | 28 Sep 2017 | 9 Years 0 Months | Current |
| Alakananda Deb | Director | 28 Sep 2017 | 9 Years 0 Months | Current |
Charges & Borrowings of Xenik Pharmaceuticals Private Limited
Xenik Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Xenik Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Xenik Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Xenik Pharmaceuticals Private Limited
Xenik Pharmaceuticals Private Limited has 4 board changes on record since 2017: 4 appointments. The latest: Alakananda Deb was appointed as Director on 28 Sep 2017.
Credit Ratings, Litigation & Regulatory Alerts for Xenik Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Xenik Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Xenik Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Xenik Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Xenik Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xenik Pharmaceuticals Private Limited
Xenik Pharmaceuticals is an active private limited company based in Silchar, Assam, India. The company works in specialty, within the trading industry. It was incorporated on 28 September 2017 (9+ years old) and is registered under CIN U51909AS2017PTC018166.
Xenik Pharmaceuticals reported revenue of ₹7.81 Lakh for FY 2019.
Xenik Pharmaceuticals has 4 current directors:
- Pijush Kanti Dev - Director
- Madhuri Dey - Director
- Sandip Dey - Director
- Alakananda Deb - Director
Xenik Pharmaceuticals reported a net profit of ₹5,801 (net margin 0.7%) and EBITDA of ₹35,885 (EBITDA margin 4.6%) for FY 2019, as per its filed financial statements.
The CIN (Corporate Identification Number) of Xenik Pharmaceuticals is U51909AS2017PTC018166. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xenik Pharmaceuticals was incorporated on 28 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Guwahati.
The peers of Xenik Pharmaceuticals by revenue are Civet Pharmaceuticals Private Limited, Wealthkind Pharmaceuticals India Private Limited, Sonrisa Pharmaceuticals Private Limited, Fulkoz Pharmaceuticals (OPC) Private Limited, Druson Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Alakananda Deb was appointed as Director on 28 Sep 2017. Madhuri Dey was appointed as Director on 28 Sep 2017. Pijush Kanti Dev was appointed as Director on 28 Sep 2017. Xenik Pharmaceuticals has 4 board changes on record in total.
The registered office of Xenik Pharmaceuticals is at CO Sandip Kumar Dey Durga Sankar Lane Ambicapatty, Silchar, Assam, India – 788004.
Xenik Pharmaceuticals has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh.
Xenik Pharmaceuticals operates in the trading industry, in the specialty segment.